Boston Scientific to Spend $40 Million on Stent Post-Op Campaign

It will also push to have patients counseled about taking blood thinners before they are discharged from the hospital. All this is coming after the controversy over whether drug-eluting stents are more likely to cause blood clots than their bare-metal counterparts. And the program is unveiled a week after two studies questioned whether stents should be used in non-emergency cases at all.  Is this good medicine? Yes. Does the timing make the company look like it's on the defensive? Yes again.